FindTrial
Sign In

The intestinal microecology changes and metabonomics-based prognostic biomarkers screening in advanced colorectal cancer patients with qi deficiency syndrome

The intestinal microecology changes and metabonomics-based prognostic biomarkers screening in advanced colorectal cancer patients with qi deficiency syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003261
Enrollment
Unknown
Registered
2013-06-13
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Group1:Qi deficiency syndrome quantitative score>8
Group 2:Yin deficiency syndrome quantitative score>10
Group 3:deficiency syndrome quantitative score<3 with no obvious excess syndrome

Sponsors

the First Affiliated Hospital of Zhejiang Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Advanced colorectal cancer patients meet criterions of western medicine and TCM with case data integrity.

Exclusion criteria

Exclusion criteria: Patients exclude jejunum tumor, appendix tumor,colorectal adenoma, E. stromal tumor,large intestine malignant melanoma and large intestine leiomyosarcoma without pathological diagnosis, and case data imcomplete.

Design outcomes

Primary

MeasureTime frame
serum metabonomics;Intestinal flora genome;—

Countries

China

Contacts

Public ContactShen Min-he
smh3288@yahoo.com.cn+86 13758186666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026